Amara Khan is a Senior Scientist in Cardiovascular Science at AstraZeneca, where they currently contribute to advancements in the field. Previously, Amara completed a PhD in Molecular Medicine at the Max Planck Institute for Multidisciplinary Sciences from 2017 to 2021 and served as a Postdoctoral Researcher at the same institute until 2022. Amara also holds a Master of Science in Cardiovascular Science from the University of Göttingen and a Bachelor of Science in Medical Bioscience from Monash University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices